| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.38 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |